About Mind-NRG
Mind-NRG is a company based in Geneve (Switzerland) founded in 2010 was acquired by Minerva Neurosciences in February 2014.. Mind-NRG has raised $9.94 million across 2 funding rounds from investors including Minerva Neurosciences and Index Ventures. Mind-NRG operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others.
- Headquarter Geneve, Switzerland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$9.94 M (USD)
in 2 rounds
-
Latest Funding Round
$7.93 M (USD), Series B
Sep 04, 2013
-
Investors
Minerva Neurosciences
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Minerva Neurosciences
(Feb 11, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Mind-NRG
Mind-NRG has successfully raised a total of $9.94M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $7.93 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $7.9M
-
First Round
First Round
(27 Oct 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2013 | Amount | Series B - Mind-NRG | Valuation |
investors |
|
| Oct, 2010 | Amount | Series A - Mind-NRG | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mind-NRG
Mind-NRG has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Minerva Neurosciences and Index Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology startups and entrepreneurs.
|
Founded Year | Domain | Location | |
|
Developing drugs against Psychiatric and other CNS Diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mind-NRG
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mind-NRG
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mind-Nrg Comparisons
Competitors of Mind-NRG
Mind-NRG operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Kriya Therapeutics, Sana Biotechnology and PureTech Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Drugs for CNS disorders are developed and advanced.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Mind-NRG
When was Mind-NRG founded?
Mind-NRG was founded in 2010.
Where is Mind-NRG located?
Mind-NRG is headquartered in Geneve, Switzerland. It is registered at Geneve, Geneve, Switzerland.
Is Mind-NRG a funded company?
Mind-NRG is a funded company, having raised a total of $9.94M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.01M, raised on Oct 27, 2010.
What does Mind-NRG do?
Mind-NRG was founded in 2010 in Geneva, Switzerland, within the biotechnology sector. Focus is placed on the development of NRG-101, a peptidic neurotrophic factor designed to cross the blood-brain barrier through receptor-mediated transport. This approach targets central nervous system diseases with potential for disease modification. Operations center on research and preclinical advancement. Acquisition by Minerva Neurosciences occurred in 2014.
Who are the top competitors of Mind-NRG?
Mind-NRG's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.
Who are Mind-NRG's investors?
Mind-NRG has 2 investors. Key investors include Minerva Neurosciences, and Index Ventures.